Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/9/2018
SIETES contiene 92559 citas

 
 
<< anterior 21 a 40 de 165 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Wang C, Graham DJ, Kane RC, Xie D, Wemecke M, Levenson M, MaCurdy TE, Houstoun M, Ryan Q, Wong S, Mott K, Sheu T-C, Limb S, Worrall C, Kelman JA, Reichman ME. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 2015;314:2062-8. [Ref.ID 99687]
22. Cita con resumen
Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, Kales HC. Antipsychotics, other psychotropics, and the risk of death in patients with dementia. Number needed to harm . JAMA Psychiatry 2015;72:438-45. [Ref.ID 98861]
23.Tiene citas relacionadas Cita con resumen
Fournier JP, Azoulay L, Yin H, Montastruc J-L, Suissa S. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med 2014;175:186-93. [Ref.ID 98791]
24. Cita con resumen
Li DQ, Kim R, McArthur E, Fleet JL, Bailey DG, Juurlink D, Shariff SZ, Gomes T, Mamdani M, Gandhi S, Dixon S, Garg AX. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. Can Med Assoc J 2015;187:174-80. [Ref.ID 98758]
25. Cita con resumen
Lamberts M, Lip GYH, Hansen ML, Lindhardsen J, Olesen JB, Raunso J, Schjerning Olsen A-M, Andersen PK, Gerds TA, Nat R, Fosbol EL, Torp-Pedersen C. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. Ann Intern Med 2014;161:690-8. [Ref.ID 98326]
26.Tiene citas relacionadas Cita con resumen
27. Cita con resumen
Anónimo. Xolair (omalizumab): drug safety communication - Slightly elevated risk of cardiovascular and cerebrovascular serious adverse events. FDA U.S. Food and Drug Administration 2014:26 de septiembre. [Ref.ID 97997]
28. Cita con resumen
Chiu WY, Chien JY, Yang WS, Juanq JM, Lee JJ, Tsai KS. The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene.. J Clin Endocrinol Metab 2014;99:2729-35. [Ref.ID 97859]
29. Cita con resumen
Weich S, Pearce HL, Croft P, Singh S, Crome I, Bashford J, Frisher M. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ 2014;348:g1996. [Ref.ID 97297]
30. Cita con resumen
Anónimo. Thalidomide: risk of second primary malignancies. Drug Safety Update 2013;6:mayo. [Ref.ID 95524]
31.Tiene citas relacionadas Cita con resumen
32. Cita con resumen
Spencer FA, Iorio A, You J, Murad MH, Schünemann HJ, Vandvik PO, Crowther MA, Pottie K, Lang ES, Meerpohl JJ, Falck-Ytter Y, Alonso-Coello P, Guyatt GH. Uncertainties in baseline risk estimates and confidence in treatment effects. BMJ 2012;345:18-21. [Ref.ID 94177]
33.Tiene citas relacionadas Cita con resumen
Herzig S, Rothberg M. Drug prophylaxis in general medical patients: does usage reflect the benefits and risks?. BMJ 2012;344:21-3. [Ref.ID 93191]
34. Cita con resumen
Prabakar I, Webb A. Emergency contraception. BMJ 2012;344:61-4. [Ref.ID 92653]
35. Cita con resumen
Moynihan R. Surrogates under scrutiny: fallible correlations, fatal consequences. BMJ 2011;343:d5160. [Ref.ID 91893]
36. Cita con resumen
Bolland MJ, Grey A. Data openness. Reporting of absolute risk. BMJ 2010;341:1063. [Ref.ID 89685]
37.Tiene citas relacionadas
Kleijer BC, Heerdink ER, van Marum RJ. Antipsychotics and venous thrombosis. Dutch experience differs. BMJ 2010;341:793. [Ref.ID 89507]
40.Tiene citas relacionadas Cita con resumen
Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ 2010;341:641. [Ref.ID 89413]
Seleccionar todas
 
<< anterior 21 a 40 de 165 siguiente >>